MENU
+Compare
INNPF
Stock ticker: OTC
AS OF
Aug 15 closing price
Price
$0.15
Change
-$0.00 (-0.00%)
Capitalization
47.84M

INNPF Innocan Pharma Corp. Forecast, Technical & Fundamental Analysis

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals... Show more

INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INNPF with price predictions
Aug 15, 2025

INNPF in downward trend: 10-day moving average moved below 50-day moving average on August 15, 2025

The 10-day moving average for INNPF crossed bearishly below the 50-day moving average on August 15, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 25 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where INNPF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on INNPF as a result. In of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for INNPF turned negative on August 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

INNPF moved below its 50-day moving average on August 15, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INNPF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

Following a +11,21 3-day Advance, the price is estimated to grow further. Considering data from situations where INNPF advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .

INNPF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 73 cases where INNPF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.681) is normal, around the industry mean (16.499). P/E Ratio (0.000) is within average values for comparable stocks, (72.127). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.761). INNPF's Dividend Yield (0.078) is considerably higher than the industry average of (0.031). P/S Ratio (1.451) is also within normal values, averaging (40.137).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. INNPF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INNPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

INNPF is expected to pay dividends on August 29, 2025

Innocan Pharma Corp. INNPF Stock Dividends
A dividend of $0.73 per share will be paid with a record date of August 29, 2025, and an ex-dividend date of August 15, 2025. The last dividend of $0.37 was paid on May 30. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
13215 Bee Cave Parkway
Phone
+1 512 538-2300
Employees
78
Web
https://www.shpreit.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPNFF0.02N/A
+4.47%
ImagineAR, Inc.
ARKAY72.611.37
+1.93%
Arkema
SVNDF13.65N/A
N/A
Seven & I Holdings Co., Ltd.
ASAAF12.52N/A
N/A
AT&S Austria Technologie & SystemTechnik AG Leoben
NYWKF1.56N/A
N/A
NTG Clarity Networks Inc.

INNPF and Stocks

Correlation & Price change

A.I.dvisor tells us that INNPF and VTRS have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNPF and VTRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNPF
1D Price
Change %
INNPF100%
-99.14%
VTRS - INNPF
10%
Poorly correlated
-0.75%
LOVFF - INNPF
6%
Poorly correlated
-0.25%
BGM - INNPF
5%
Poorly correlated
-0.07%
VPHIF - INNPF
4%
Poorly correlated
N/A
TSMRF - INNPF
0%
Poorly correlated
N/A
More

Groups containing INNPF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNPF
1D Price
Change %
INNPF100%
-99.14%
Pharmaceuticals: Generic
industry (228 stocks)
19%
Poorly correlated
-1.77%